Inflammatory Myofibroblastic Tumor of Extremities.
10.5292/jkbjts.2013.19.1.14
- Author:
Chang Bae KONG
;
Jeong Dong LEE
;
Jung Uk LEE
;
Won Seok SONG
;
Wan Hyeong CHO
;
Jae Soo KOH
;
Dae Geun JEON
- Publication Type:Original Article
- Keywords:
inflammatory myofibroblastic tumor;
extremities;
margin;
wide resection
- MeSH:
Arteries;
Extremities;
Female;
Fibrosarcoma;
Follow-Up Studies;
Humans;
Liver;
Lung;
Lymph Nodes;
Myofibroblasts;
Neoplasm Metastasis;
Recurrence
- From:The Journal of the Korean Bone and Joint Tumor Society
2013;19(1):14-19
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We analyzed the oncologic characteristics and outcome of patients with inflammatory myofibroblastic tumor of extremities. MATERIALS AND METHODS: Among the soft tissue tumor patients who were treated between 1999 and 2012, 5 patients who were pathologically confirmed as the inflammatory myofibroblastic tumor of extremities were analyzed retrospectively. RESULTS: There were 1 man and 4 women with mean age of 44 years (37-55 years). The average follow up was 34.6 months (8-87 months). All patients underwent surgical treatment. Only 1 patient had wide resection margin and remaining 4 had marginal (3) or intralesional (1) resection margin. All of 4 patients without wide resection margin developed local recurrence at 10.3 months (8-19 months). Malignant transformation to fibrosarcoma was occurred in 2 patients who developed local recurrence, and 1 patient developed multiple metastases to lung, liver and lymph nodes and expired at 37 months. Three of 5 patients had tumor location abutted to or invasion to major arteries and 1 patient had tumor invading sciatic nerve. CONCLUSION: It is observed that inflammatory myofibroblastic tumor of extremities is usually located near the major neurovascular structure. Wide resection should be considered as the initial surgical treatment because this tumor showed a high local recurrence rate and possibility of malignant transformation.
